期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
机械分流泵防治门脉高压食管静脉曲张破裂出血的动物实验研究
1
作者 文武魁 洪文光 +2 位作者 陈静明 谢燕珍 陈镇武 《临床医学工程》 2012年第8期1253-1255,共3页
目的通过实验犬门脉高压模型验证机械泵门体分流对防治门脉高压食管静脉曲张破裂出血的有效性和安全性。方法 24条实验成年犬行腹部手术采用门脉主干捆绑气囊导管引出体外注水的方式制成门脉高压动物模型,同时行门脉插管,出现食管静脉... 目的通过实验犬门脉高压模型验证机械泵门体分流对防治门脉高压食管静脉曲张破裂出血的有效性和安全性。方法 24条实验成年犬行腹部手术采用门脉主干捆绑气囊导管引出体外注水的方式制成门脉高压动物模型,同时行门脉插管,出现食管静脉曲张破裂出血后随机分为机械泵持续门体分流A组和保守治疗B组治疗时间1周,分别对门脉压改变、止血率、血液主要有形成份及病死率进行检测记录。结果 24条模型犬均出现门脉高压食管静脉曲张破裂出血,A、B两组发生出血的时间和门脉压升高程度以及血红蛋白降低程度无明显差异。治疗后A组门脉压降低程度、止血率明显高于B组。病死率则明显低于B组(P<0.01)。A组使用机械分流泵未见血液成份明显机械损伤。结论使用机械分流泵在大型动物中行门体分流可以快速、可控降低门静脉压,从而即时、高效、确切中止门脉压食管静脉破裂出血。中长时段的机械分流对血液成份无明显损伤。 展开更多
关键词 门脉高压并食管静脉曲张破裂大出血 实验犬 门脉高压模型 门体机械分流泵
下载PDF
丹参、心得安对门静脉高压症大鼠门静脉压力、肝纤维化指标及胃肠激素的影响 被引量:5
2
作者 徐晓琦 李民 +8 位作者 顾尔莉 章幼奕 窦志华 罗琳 徐济良 陈鸣鸣 陈淑范 葛春霞 朱浩然 《浙江中医药大学学报》 CAS 2010年第3期312-313,共2页
[目的]观察丹参、心得安对门脉高压大鼠门静脉压力、肝纤维化指标及胃肠激素的影响。[方法]采用CCL4加酒精饮料制作大鼠门脉高压模型,造模四周后分别给大鼠服用丹参、心得安,造模结束后用Medlab-Ug4Cs生物信号采集处理系统检测正常组、... [目的]观察丹参、心得安对门脉高压大鼠门静脉压力、肝纤维化指标及胃肠激素的影响。[方法]采用CCL4加酒精饮料制作大鼠门脉高压模型,造模四周后分别给大鼠服用丹参、心得安,造模结束后用Medlab-Ug4Cs生物信号采集处理系统检测正常组、模型组、丹参治疗组、心得安治疗组大鼠门静脉压力。处死大鼠后颈动脉取血,用放免法检测正常组、模型组、心得安治疗组、丹参治疗组大鼠血浆胃肠激素的含量、肝纤维化指标。[结果]模型组门静脉压力较正常组明显升高(P<0.01),丹参量治疗组、心得安治疗组门脉压力较模型组明显下降(P<0.01),胃泌素、胰高血糖素明显下降(P<0.05)。丹参治疗组胃泌素、胃动素、胰高血糖素含量与模型组比较明显下降(P<0.01或0.05),与心得安治疗比较胃动素、胃泌素、胰高血糖素下降明显(P<0.05)。[结论]丹参能有效降低门脉高压大鼠门静脉压力、肝纤维化指标,调节胃肠激素,疗效优于心得安治疗组。 展开更多
关键词 肝纤维化 门脉高压模型 丹参 心得安 胃肠激素 肝功能
下载PDF
Stability of a rat model of prehepatic portal hypertension caused by partial ligation of the portal vein 被引量:8
3
作者 Zhe Wen Jin-Zhe Zhang +2 位作者 Hui-Min Xia Chun-Xiao Yang Ya-Jun Chen 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第32期4049-4054,共6页
AIM: To study the stability of portal hypertension (PHT) caused by partial ligation of the portal vein ligation (PVL) in a rat model.METHODS: Thirty male adult Wistar rats were divided into two groups: 10 in Gr... AIM: To study the stability of portal hypertension (PHT) caused by partial ligation of the portal vein ligation (PVL) in a rat model.METHODS: Thirty male adult Wistar rats were divided into two groups: 10 in Group Ⅰ received a sham operation; and 20 in Group Ⅱreceived partial PVL. Portal vein pressure (PVP) was measured at four time periods: before ligation, 2 wk, 6 wk and 10 wk postsurgery. Portal venography, blood sampling and liver and spleen pathological examinations were conducted at 10 wk after surgery.RESULTS: The PVP was 9.15± 0.58 cmH2O before ligation, and increased to 17.32 ±0.63 cmH2O 2 wk after PVL. By repeat measurement of the PVP in each rat, it was shown to remain elevated for 10 wk. There were no significant differences in the pressure measurements at 2 wk, 6 wk and 10 wk. Varices were found mainly in the mesenteric vein 2 wk after PVL, which were more obvious later, while these manifestations were similar at week 6 and week 10. Portal venography demonstrated the varices and collaterals. There was no significant change in liver pathology. The volume of the spleen was enlarged 2-fold after ligation, and the sinus of the spleen was enlarged due to congestion. Significant sinus endothelial cell proliferation was observed, but no evidence of hypersplenia was found on hemogram and biochemical examination.CONCLUSION: These findings suggest that a satisfactory prehepatic PHT rat model can be obtained by partial ligation of the portal vein, and this PHT rat model was stable for at least 10 wk. 展开更多
关键词 LIGATION Portal hypertension Portal vein RAT
下载PDF
Bile duct ligation in rats: A reliable model of hepatorenal syndrome? 被引量:10
4
作者 Stelios F Assimakopoulos Constantine E Vagianos 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第1期121-123,共3页
The two most widely used experimental models of advanced liver disease are the administration of carbon tetrachloride, and common bile duct ligation (BDL), however, neither has been systematically evaluated as a model... The two most widely used experimental models of advanced liver disease are the administration of carbon tetrachloride, and common bile duct ligation (BDL), however, neither has been systematically evaluated as a model of hepatorenal syndrome (HRS). The BDL model in rats, studied at diverse time points, induced a progressive renal dysfunction without structural changes in the kidney. The authors concluded that BDL is a good model for further studies of HRS and its treatment. However, the renal impairment observed at the acute phase of the BDL model is based on a different pathophysiology than that of HRS. Specifi cally, in acute obstructive jaundice, cholemia predominates over parenchymal liver disease (reversible at this stage without portal hypertension or cirrhosis) and independently induces negative inotropic and chronotropic effects on the heart, impaired sympathetic vasoconstriction response and profound natriuresis and diuresis that might lead to volume depletion. In addition, systemic endotoxemia contributes to the prerenal etiology of renal impairment and promotes direct nephrotoxicity and acute tubular necrosis. On the other hand, the renal failure observed in the chronic BDL model (with development of biliary cirrhosis, portal hypertension and ascites) shares pathophysiological similarities with HRS, but the accordance of the chronic BDL model to the diagnostic criteria of HRS (e.g. absence of spontaneous bacterial peritonitis, no renal function improvement after plasma volume expansion) should have been confirmed. In conclusion, we think that the BDL model is not suitable for the study of the natural history of HRS, but the chronic BDL model might be valid for the study of established HRS and its potential therapies. 展开更多
关键词 Obstructive jaundice RATS Bile ductligation Hepatorenal syndrome Renal failure
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部